- Details
- Press Release
The Sami-Sabinsa Group was honored with numerous awards in recent weeks, being named “best of” in categories ranging from herbal research to beverage taste. The Sami-Sabinsa Group’s founder, Chairman, and Managing Director, Dr. Muhammed Majeed, was commended as well.
- Details
- Press Release
Sabinsa’s founder, Chairman, and Managing Director Dr. Muhammed Majeed announced the publication of a new book; this latest is entitled “Reductive Metabolites of Curcuminoids.” Over the last two decades curcuminoids have been the most intensively studied herbal constituents, and Sabinsa has been at the forefront of much of the research.
- Details
- Press Release
Sabinsa is the official Curcumin Sponsor of SupplySide West, to be held October 17 - 18, 2019, at the Mandalay Bay Convention Center, Las Vegas, NV. The company will highlight several condition-specific branded ingredient products from its extensive portfolio in booth #4131.
- Details
- Press Release
The body of research supporting efficacy of Sabinsa’s branded ingredients continues to grow with a recent clinical paper reporting on the use of the company’s Curcumin C3 Complex® and BioPerine®, and taurine on hepatocellular carcinoma (HCC) patients: A combined treatment of curcumin, piperine, and taurine alters the circulating levels of IL-10 and miR-21 in hepatocellular carcinoma patients: a pilot study published in the Journal of Gastrointestional Oncology.
- Details
- Press Release
Sabinsa’s Curcumin C3 Complex® in combination with BioPerine® (CBP) has an inhibitory effect on malignant mesothelioma cells, according to an in vitro and in vivo study published in Journal of Experimental and Clinical Cancer Research.